bioRxiv · 10.1101/2020.11.09.374082
SARS-CoV-2 epitope mapping on microarrays highlights strong immune-response to N protein region
Abstract
A workflow for SARS-CoV-2 epitope discovery on peptide microarrays is herein reported. The process started with a proteome-wide screening of immunoreactivity based on the use of a high-density microarray followed by a refinement and validation phase on a restricted panel of probes using microarrays with tailored peptide immobilization through a click-based strategy. Progressively larger, independent cohorts of Covid-19 positive sera were tested in the refinement processes, leading to the identification of immunodominant regions on SARS-CoV-2 Spike (S), Nucleocapsid (N) protein and Orf1ab polyprotein. A summary study testing 50 serum samples highlighted an epitope of the N protein (region 155-171) providing 92% sensitivity and 100% specificity of IgG detection in Covid-19 samples thus being a promising candidate for rapid implementation in serological tests.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Musico, A., Frigerio, R., Mussida, A., Barzon, L., Sinigaglia, A., Riccetti, S., Gobbi, F., Piubelli, C., Bergamaschi, G., Chiari, M., Gori, A., Cretich, M.. 2020-11-09. SARS-CoV-2 epitope mapping on microarrays highlights strong immune-response to N protein region. https://doi.org/10.1101/2020.11.09.374082
Cite the original work for its findings. Save a collection to share your selection of sources.